| Gene symbol | VEGFA | Synonyms | L-VEGF, MVCD1, VEGF, VPF | Type of gene | protein-coding |
| Chromosome | 6 | Map location | 6p21.1 | dbXrefs | |
| Gene perturbation-related omics dataset | PerturbAtlas | PertOrg | ||||
| Description | vascular endothelial growth factor A | ||||
| GTO ID | GTC1278 |
| Trial ID | NCT00531336 |
| Disease | Macular Degeneration |
| Altered gene | VEGFA |
| Therapeutic/Target gene | Target gene |
| Therapy | Aptamer |
| Treatment | Macugen|pegaptanib|EYE001 |
| Co-treatment | Avastin |
| Phase | Phase2 |
| Recruitment status | Completed |
| Title | Comparison of Combined Therapy of Intravitreal Injection of Avastin and Macugen Versus Mono-Therapy The MAAM Study - a Pilot Study |
| Year | 2006 |
| Country | Austria |
| Company sponsor | The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery |
| Other ID(s) | EK06-001839-18 |
| Cohort1: pegaptanib_Avastin | |||||||
|
|||||||
| Cohort2: Avastin | |||||||
|
|||||||
| Cohort3: pegaptanib | |||||||
|
|||||||